See more : Groupe Plus-Values SA (MLPVG.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Changming Industrial Management Group Holding (CMIM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Changming Industrial Management Group Holding, a leading company in the Industrial Materials industry within the Basic Materials sector.
- Azbil Corporation (6845.T) Income Statement Analysis – Financial Results
- Companhia Paranaense de Energia – COPEL (ELP) Income Statement Analysis – Financial Results
- Nelcast Limited (NELCAST.NS) Income Statement Analysis – Financial Results
- Scryb Inc. (SCYRF) Income Statement Analysis – Financial Results
- Iofina plc (IOF.L) Income Statement Analysis – Financial Results
Changming Industrial Management Group Holding (CMIM)
Industry: Industrial Materials
Sector: Basic Materials
About Changming Industrial Management Group Holding
Changming Industrial Management Group Holding provides hospital management consultancy services to VIP maternity and gynecological centers (VIP Birthing Centers) in China. It also manages a private hospital in Macau. The company's obstetric services include outpatient services such as pre-delivery check-up and consultation, and prenatal genetic consultation; and inpatient and minor surgery services, including vaginal birth, caesarean, and prenatal education. Its gynecology services comprise various outpatient services consisting of gynecologic check up and pre-marriage body checkup; and inpatient and minor surgery services, such as gynecologic minor operation and minor operation for planned childbirth. The company was formerly known as China Health Care Corporation and changed its name to Changming Industrial Management Group Holding in February 2019. Changming Industrial Management Group Holding was founded in 2001 and is based in Wan Chai, Hong Kong.
Metric | 2020 | 2019 | 2008 | 2007 |
---|---|---|---|---|
Revenue | 6.19M | 4.42M | 545.88K | 0.00 |
Cost of Revenue | 5.24M | 3.88M | 168.11K | 0.00 |
Gross Profit | 952.94K | 538.16K | 377.77K | 0.00 |
Gross Profit Ratio | 15.40% | 12.19% | 69.20% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 193.34K | 239.63K | 2.80M | 32.98K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 193.34K | 239.63K | 2.80M | 53.59K |
Cost & Expenses | 5.43M | 4.12M | 2.97M | 53.59K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 27.55K | 14.41K | 279.94K | 0.00 |
EBITDA | 786.83K | 312.80K | -2.14M | -53.59K |
EBITDA Ratio | 12.71% | 7.08% | -393.71% | 0.00% |
Operating Income | 759.60K | 298.53K | -2.42M | -53.59K |
Operating Income Ratio | 12.27% | 6.76% | -443.42% | 0.00% |
Total Other Income/Expenses | -321.00 | -126.00 | -205.03K | -68.00 |
Income Before Tax | 759.28K | 298.40K | -2.66M | -53.65K |
Income Before Tax Ratio | 12.27% | 6.76% | -487.93% | 0.00% |
Income Tax Expense | 111.73K | 63.12K | 20.11K | 0.00 |
Net Income | 647.55K | 235.28K | -2.72M | -53.65K |
Net Income Ratio | 10.46% | 5.33% | -498.18% | 0.00% |
EPS | 0.00 | 0.00 | 0.00 | -0.09 |
EPS Diluted | 0.00 | 0.00 | 0.00 | -0.09 |
Weighted Avg Shares Out | 204.18M | 204.18M | 0.00 | 578.75K |
Weighted Avg Shares Out (Dil) | 204.18M | 204.18M | 0.00 | 578.75K |
Source: https://incomestatements.info
Category: Stock Reports